Second-year safety Calen Bullock is a standout again; the first-team offensive line starts to take shape; and rookie Kyonte ...

CNBC's Jim Cramer on Tuesday reviewed Figma, a design software company set to go public this week. Although he said he likes ...

Eli Lilly (LLY) recently received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) for its Alzheimer's drug donanemab, underscoring the company's advancements in a ...

Port Angeles’ Day of Play, music and stage performances highlight weekend events on the North Olympic Peninsula.

Gate Bioscience Inc. has entered a collaboration and license agreement with Eli Lilly and Co. to discover, develop and ...

Eli Lilly is walking through the Gate, inking a deal worth up to $856 million with a biotech aiming to build out a new ...

Dave Hinton is editor of The News-Gazette's 'Our Communities' section. He can be reached at [email protected].

Eli Lilly (LLY) recently entered a collaboration with Gate Bioscience to develop molecular gate therapeutics, a move that ...

California’s Gate Bioscience, a biotech developing molecular gates, a new class of small molecule drugs to eliminate ...

The gene therapy developer is cutting 30% of its workforce. Elsewhere, Abivax secured a major cash infusion, while Novartis and Eli Lilly struck research deals.

Collaboration combines Gate Bioscience's Molecular Gate drug discovery engine with Lilly's expertise in small molecule therapeutics. Company to receive an upfront payment, an equity investment, ...

Midsize U.S. metros are driving job growth, attracting talent, reshaping local economies, and offering a vibrant social scene ...